These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 20857647)
1. Vaccines to antibodies: grow up! von Bubnoff A IAVI Rep; 2010; 14(4):4-9. PubMed ID: 20857647 [TBL] [Abstract][Full Text] [Related]
2. HIV vaccine development--improving on natural immunity. Johnston MI; Fauci AS N Engl J Med; 2011 Sep; 365(10):873-5. PubMed ID: 21899447 [No Abstract] [Full Text] [Related]
3. AIDS/HIV. A boost for HIV vaccine design. Burton DR; Weiss RA Science; 2010 Aug; 329(5993):770-3. PubMed ID: 20705840 [No Abstract] [Full Text] [Related]
4. As antibody findings mount, what comes next? Interview by Kristen Jill Kresge and Regina McEnery. Burton D; Mascola J; Michael N; Overbaugh J IAVI Rep; 2011; 15(1):4-7. PubMed ID: 21449503 [No Abstract] [Full Text] [Related]
5. Current world literature. Curr Opin HIV AIDS; 2009 Sep; 4(5):453-7. PubMed ID: 20046137 [No Abstract] [Full Text] [Related]
6. Antibody fever. von Bubnoff A IAVI Rep; 2010; 14(2):4-10. PubMed ID: 20496658 [No Abstract] [Full Text] [Related]
7. Challenges for structure-based HIV vaccine design. Schief WR; Ban YE; Stamatatos L Curr Opin HIV AIDS; 2009 Sep; 4(5):431-40. PubMed ID: 20048708 [TBL] [Abstract][Full Text] [Related]
8. Infectious disease. An enterprising time for HIV vaccine research. Cohen J Science; 2012 Sep; 337(6101):1446. PubMed ID: 22997300 [No Abstract] [Full Text] [Related]
9. HIV vaccine design and the neutralizing antibody problem. Burton DR; Desrosiers RC; Doms RW; Koff WC; Kwong PD; Moore JP; Nabel GJ; Sodroski J; Wilson IA; Wyatt RT Nat Immunol; 2004 Mar; 5(3):233-6. PubMed ID: 14985706 [No Abstract] [Full Text] [Related]
10. The antibody race. von Bubnoff A IAVI Rep; 2013; 17(1):12-5, 19. PubMed ID: 23678537 [No Abstract] [Full Text] [Related]
11. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations. Ahlers JD; Pendleton CD; Dunlop N; Minassian A; Nara PL; Berzofsky JA J Immunol; 1993 Jun; 150(12):5647-65. PubMed ID: 8515081 [TBL] [Abstract][Full Text] [Related]
16. Mapping the journey to an HIV vaccine. Ackerman M; Alter G N Engl J Med; 2013 Jul; 369(4):389-91. PubMed ID: 23883384 [No Abstract] [Full Text] [Related]
17. Antibodies: beyond neutralization. von Bubnoff A IAVI Rep; 2010; 14(1):8-12. PubMed ID: 20349583 [No Abstract] [Full Text] [Related]
18. Structure-function in HIV research. Interview by Simon Noble. Burton D IAVI Rep; 2007; 11(1):10-3. PubMed ID: 20210120 [No Abstract] [Full Text] [Related]
19. A pathway to HIV-1 neutralization breadth. Smith SA; Derdeyn CA Nat Med; 2015 Nov; 21(11):1246-7. PubMed ID: 26540383 [TBL] [Abstract][Full Text] [Related]
20. New center focuses on neutralizing antibodies. McEnery R IAVI Rep; 2008; 12(5):15. PubMed ID: 20210066 [No Abstract] [Full Text] [Related] [Next] [New Search]